4D Molecular Therapeutics (FDMT)
(Delayed Data from NSDQ)
$25.70 USD
+0.06 (0.23%)
Updated May 10, 2024 04:00 PM ET
After-Market: $25.68 -0.02 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.75 | 4.00% |
Earnings Summary
For their last quarter, 4D Molecular Therapeutics (FDMT) reported earnings of -$0.66 per share, beating the Zacks Consensus Estimate of $-0.73 per share. This reflects a positive earnings surprise of 9.59%. Look out for FDMT's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.75 per share, reflecting a year-over-year increase of 2.6%.
Earnings History
Price & Consensus
Zacks News for FDMT
4D Molecular Therapeutics, Inc. (FDMT) Reports Q4 Loss, Misses Revenue Estimates
FDMT: What are Zacks experts saying now?
Zacks Private Portfolio Services